Company Filing History:
Years Active: 2006
Title: Cherida Rachel Dhore: Innovator in Equine Herpesvirus Research
Introduction
Cherida Rachel Dhore is a notable inventor based in Tegelen, Netherlands. She has made significant contributions to the field of veterinary medicine, particularly in the development of vaccines for equine diseases. Her innovative work has led to the creation of a patented technology that addresses critical health issues in horses.
Latest Patents
Cherida holds a patent for an attenuated equine herpesvirus. The present invention relates to novel Equine herpesvirus (EHV) mutants comprising one or more deletions, substitutions, or insertions in the endogenous promoter region of an essential viral gene, preferably the immediate early gene of EHV. The EHV mutants are stable and have reduced virulence, making them very suitable for use in a live vaccine. The invention furthermore relates to live vaccines comprising said EHV mutants, to DNA sequences and vectors harboring a mutated EHV sequence, and to host cells transfected with said DNA or vectors. Additionally, the invention also relates to a method of attenuating EHV in general, and EHV-1 in particular.
Career Highlights
Cherida is associated with Akzo Nobel N.V., where she applies her expertise in virology and vaccine development. Her work has been instrumental in advancing the understanding of equine herpesvirus and its implications for horse health.
Collaborations
Cherida has collaborated with notable colleagues, including Paulus Jacobus Antonius Sondermeijer and Nicolaas Visser. These partnerships have enhanced her research and contributed to the successful development of her patented technology.
Conclusion
Cherida Rachel Dhore's innovative work in the field of equine herpesvirus research exemplifies her commitment to improving animal health through scientific advancements. Her contributions are vital for the development of effective vaccines, ensuring better health outcomes for horses.